Help fund research on retinoblastoma, a child eye cancerSpain
It originates from the developing retina and usually presents in patients under 3 years of age. While the retinoblastoma cure rate is higher than 90%, traditionally patients with advanced intraocular disease tended to require enucleation (surgical removal) of the affected eye, despite conservative treatments. We apply treatments adapted to the characteristics of each patient and we are referring in¡ the application of our therapies. Our cure rate is over 95%
Total raised €67%raised
Hawkers clients 6.773€
Those people who have naturally benefited from the project's interventions.
Those identifiable people who will potentially recieve an effect from the project's activities.
- Funding 10.000€
- Total 10.000€
SJD Barcelona Children's Hospital has led the way in Europe in introducing intra-arterial chemotherapy, which applies localised chemotherapy to the tumour and preserves the eye affected by the disease.
Intra-arterial chemotherapy consists of inserting a catheter into an artery in the child's groin and then advancing it towards an artery in the eye to administer chemotherapy to the tumour. This technique allows chemotherapeutic agents to better reach the tumour and makes it possible to reduce the dose of chemotherapy that the body receives. In this way, adverse effects are reduced and patient and family quality of life is improved.
At SJD Barcelona Children's Hospital, we take a multidisciplinary approach to disease involving the best ophthalmologists with expertise in the retina, radiotherapists and oncologists.
- Finding new ways to treat retinoblastoma.
- Avoid having to remove the balloon to occupy certain patients with retinoblastoma and reduce the cases of blindness in children who suffer from this disease.
Who will benefit?
Children with retinoblastoma.
Research on the treatment of retinoblastoma, and reducing cases of blindness in children who suffer from this disease.
Updates & Links